Posted on 9/14/20

Jounce Therapeutics: An Undervalued Biotech Flush With Big Pharma Cash

SummaryJounce therapeutics is a differentiated player in the hot immuno-oncology sector.JNCE stock has not been fairly priced after its newly struck partnership with Gilead Sciences, making . . .